Shanghai HyaMab Biotechnology Co., Ltd., headquartered in Shanghai's Zhangjiang Innovation Cluster Pharmaceutical Valley, is focused on developing new anti-cancer drugs with BIC/FIC potential, such as mAbs and engineered immune cells. The company collaborates with leading international labs and R&D teams including Ruizhi Medicine and the Institute of Immunology at Shanghai University of Science and Technology. The company's strategy is to harness the power of innate immunity, particularly NK cells, to fight the spread of cancer cells.

Disease Domain	Count

Neoplasms	10
Hemic and Lymphatic Diseases	2
Nervous System Diseases	1
Immune System Diseases	1

Top 5 Drug Type	Count

Monoclonal antibody	4
Cell therapy	3
Antibody	3

Top 5 Target	Count

CD47(Cluster of differentiation 47)	1
NKG2A(killer cell lectin like receptor C1)	1
PD-1(Programmed cell death protein 1)	1
4-1BB(Tumor necrosis factor receptor superfamily member 9)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 06 Oct 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Phase 1 Clinical

Phase 2 Clinical

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

PE-0116 ( 4-1BB )	Advanced Malignant Solid Neoplasm More	Phase 2 Clinical
Recombinant human anti-PD-1 monoclonal antibody(Shanghai Yunyi Health Technology Development Co Ltd) ( PD-1 )	Advanced Malignant Solid Neoplasm More	Phase 2 Clinical
HY-0102 ( NKG2A )	Solid tumor More	Phase 1
c4D10 ( CD47 )	Neoplasms More	Preclinical
HY001001	Solid tumor More	Discovery

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis